Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to compare the efficacy of 6 dose levels of oral CP 690,550 (20 mg once daily [QD] and 15 mg, 10 mg, 5 mg, 3 mg and 1 mg twice daily [BID]), versus placebo, for the treatment of signs and symptoms, administered over 12 weeks, in subjects with active RA on a stable background of MTX who have had an inadequate response to MTX alone.
Critère d'inclusion
- Rheumatoid Arthritis